We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
importance of establishing wild type RAS (KRAS and NRAS) status before treatment of metastatic colorectal cancer
Extra funding this government has provided for cancer drugs has helped almost 18,500 people since October 2010.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Monitoring one-year survival will be central to measuring progress in transforming cancer care, the Health and Social Care Secretary, Matt Hancock, announced today.
First published during the 2015 to 2016 Cameron Conservative government
More people suffering from cancer will get the unconditional help they need under new proposals.
Increased risk of stroke in older women should be taken into account in prescribing decisions.
UK update on Breast Implant Associated - Anaplastic Large Cell Lymphoma (BIA - ALCL)
(Q-Med AB - a Galderma division) problem with use of Macrolane VRF20 and Macrolane VRF30 for breast augmentation which can make diagnosis of breast cancer more difficult. (MDA/2012/022)
Patients could receive earlier and more accurate diagnoses for potentially life-threatening diseases such as cancer and Crohn’s disease, thanks to £16 million of new funding
First published during the 2019 to 2022 Johnson Conservative government
Severe infusion-related hypersensitivity reactions have occurred in patients receiving temsirolimus.
Anti-cancer therapy with carfilzomib has been associated with cases of cardiac arrest, cardiac failure, and myocardial infarction, including in patients without pre-existing cardiac disorders. Monitor patients for signs and symptoms of cardiac disorders before and during exposure to carfilzomib.
(Lipomatrix Inc) conclusions of research after device was recalled for risks of break down of filler and update of HN2000(05). (MDA/2004/047)
Thousands of NHS patients could receive faster diagnosis and better treatment for life-changing diseases like cancer, dementia and Parkinson’s.
Employment Tribunal decision.
The government has announced a renewed focus on brain cancer research, in honour of Tessa Jowell.
First published during the 2016 to 2019 May Conservative government
The Cell and Gene Therapy Catapult has announced the sale of its subsidiary to biotechnology company, Cell Medica.
Brain tumour research in the UK to receive £45 million in funding from the Department of Health and Social Care and Cancer Research UK.
Recombinant human erythropoietin (r-HuEPO) treatment has been associated with very rare cases of life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Withdraw r-HuEPOs permanently in patients who develop severe skin reactions such as...
Risk of meningioma with cyproterone acetate increases with increasing cumulative dose. Use of cyproterone is contraindicated in patients with previous or current meningioma (for all indications) and should only be considered for control of libido in severe hypersexuality or paraphilias...
The funding is double the original amount and will be used to encourage new research and clinical practice to improve outcomes for people with brain tumours.
Monitoring technology takes just a finger prick to carry out a blood test count that helps chemotherapy patients to manage their treatment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).